Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2021 Earnings

11FebConfirmed

Q2 2020

Q3 2020

Q4 2020

Q1 2021

-12.04

-10.8

-9.56

-8.32

Details

Expected EPS

-9.604245

Actual EPS

-11.213894999999999

Surprise EPS

-1.61

Surprise Percent

+16.76%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -11.213894999999999 per share for Q1 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.